Chenxin Pharmaceutical: Shisi Yao plans to reduce its shareholding by no more than 1%.

Chenxin Pharmaceuticals announced that shareholder Shijiazhuang Siyao Co., Ltd., holding 6.11% of the shares, plans to reduce its holdings by no more than 4.527 million shares through centralized bidding from September 22, 2025 to December 20, 2025. The reduction ratio will not exceed 1% of the total share capital of the company, and the above-mentioned shares are acquired through agreement transfer.